Copy
See below for a daily digest of the latest Huntington's Disease news!

Taube Philanthropies Donates $3 Million to Stanford, Gladstone for Huntington’s Research

May 11, 2017 09:30 am | Carolina Henriques

 

Taube donationTaube Philanthropies has donated $3 million to fund a research team using gene editing and stem cell techniques to develop treatments for Huntington’s disease. The team is composed of Dr. Matthew Porteus and Dr. Frank Longo of Stanford Medicine, and Dr. Steve Finkbeiner of the Gladstone Institutes, said a Stanford press release. It will also collaborate with the Memory and Aging Center at the University […]

The post Taube Philanthropies Donates $3 Million to Stanford, Gladstone for Huntington’s Research appeared first on Huntington's Disease News.

Read More
share on Twitter Like Taube Philanthropies Donates $3 Million to Stanford, Gladstone for Huntington’s Research on Facebook

Huntington’s May Be Caused by Disrupted Transport of Molecules Within Neurons

May 09, 2017 02:25 pm | Joana Fernandes, PhD

 

moleculesDisruption in the trafficking of molecules in and out of the cell’s nucleus may contribute to the pathology of Huntington’s disease, according to results of recent research. The study “Mutant Huntingtin Disrupts The Nuclear Pore Complex” was published in the journal Neuron. Huntington’s disease is caused by mutations in the gene encoding the protein huntingtin (HTT), […]

The post Huntington’s May Be Caused by Disrupted Transport of Molecules Within Neurons appeared first on Huntington's Disease News.

Read More
share on Twitter Like Huntington’s May Be Caused by Disrupted Transport of Molecules Within Neurons on Facebook

Recent Posts

Phase 1/2 Trial of SBT-20 In Early-stage Huntington’s Begins in Holland
Treatment with VX15 May Protect Brain in Early Phase Huntington’s, Data Shows
Clinical Trial Results Suggest Teva’s Pridopidine May Delay Functional Decline in Huntington’s Patients
Pope Francis to Meet in Vatican with Large Contingent from Global Huntington’s Community
Results of Probiodrug AG Mouse Study to be Presented at HD Therapeutics Conference

Copyright © 2017 BioNews Services, LLC, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences